We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Council on Pharmacy and Chemistry

JAMA. 1942;120(2):124-125. doi:10.1001/jama.1942.02830370036010.
Text Size: A A A
Published online


Dennie, C. C., and McBride, W. L.:  Treatment of Arsphenamine Dermatitis, Mercurial Poisoning and Lead Intoxication , J. A. M. A. 83: 2082 ( (Dec. 27) ) 1924.
Link to Article[[XSLOpenURL/10.1001/jama.1924.02660260026009]]
Haag, H. B., and Bond, W. R.:  Value of Sodium Thiosulphate in Poisoning from Oral Administration of Arsenic , J. A. M. A. 88: 1219 ( (April 16) ) 1927.
Link to Article[[XSLOpenURL/10.1001/jama.1927.02680420009004]]
Moore, J. E., and others: The Modern Treatment of Syphilis , ed. 2, Springfield, Ill., Charles C. Thomas, Publisher, 1941.
Haskell, C. C.; Henderson, W. C., and Hamilton, J. R.:  Sodium Thiosulfate in Mercurial Poisoning , J. A. M. A. 85: 1808 ( (Dec. 5) ) 1925.
Link to Article[[XSLOpenURL/10.1001/jama.1925.02670230040011]]
Young, A. G., and Taylor, F. L., assisted by Eleanor R. Shea:  Effect of Sodium Thiosulfate on Mercury Poisoning , J. Pharmacol. & Exper. Therap. 42:185, 1931.
Rosenthal, S. M.:  Experimental Studies on Acute Mercurial Poisoning , Pub. Health Rep. 48: 1543, 1933.
Oppenheim, M., and Fantl, P.:  Das Natrium thiosulfat in der Behandlung von durch Arsenbindungen verursachten Hauterkrankungen , Arch. f. Dermat. u. Syph. 175:438, 1937.
Harrison, L. W.:  Effect of Sodium Thiosulfate on the Therapeutic Power of Arsphenamine Compounds , Lancet 1: 1161 ( (May 30) ) 1925.
Voegtlin, Carl; Dyer, H. A., and Leonard, C. S.:  On the Specificity of the So-Called Arsenic Receptor in the Higher Animals , J. Pharmacol. & Exper. Therap. 25:297, 1925.
Voegtlin, Carl, and Dyer, H. A.:  Arsphenamine-Sodium Thiosulfate Treatment of Experimental Syphilis , Pub. Health Rep. 42:1045 ( (April 15) ) 1927.
Myers, C. N.; Groehl, M. R., and Metz, G. P.:  Therapeutic Activity of Sodium Thiosulfate , Proc. Soc. Exper. Biol. & Med. 23: 97-101, 1925-1926.
Myers, C. N.; Marples, E.; Groehl, M. R., and Throne, B.:  The Use of Sodium Thiosulfate in Diagnostic Procedures , J. Lab. & Clin. Med. 11:836, 1926.
Mattice, Marjorie R.;; Baxt, Herman, and Byrne, John M.:  Effect of Thiosulfate on Arsenic Excretion , Arch. Dermat. & Syph. 42: 399-404 ( (Sept.) ) 1939.
Kuhn, H., and Loevenhart, A. S.:  The Antagonism Between Sodium Thiosulfate and Arsenical Compounds , J. Pharmacol. & Exper. Therap. 25: 160, 1925.
Kuhn, H. A., and Reese, H. H.:  Sodium Thiosulfate in Treatment of Metallic Intoxication , J. A. M. A. 85: 1804 ( (Dec. 5) ) 1925.
Mattice, Marjorie R., and Weisman, Donald:  Urinary Excretion of Arsenic , Am. J. M. Sc. 193: 413 ( (March) ) 1937.
Muir, Kathleen B.; Stenhouse, Evangeline, and Becker, S. William:  Action of Sulfur-Containing Compounds in Arsenical and Mercurial Poisoning , Arch. Dermat. & Syph. 41:308 ( (Feb.) ) 1940.
Curtis, A. C., and Young, A. G.:  Studies of the Action of Sodium Thiosulfate in Metallic Intoxication: II. The Effect of Sodium Thiosulfate on the Excretion of Lead , J. Lab. & Clin. Med. 13:628, 1928.
Shaffer, L. W.:  Treatment of Postarsphenamine Dermatitis , Arch. Dermat. & Syph. 29:173 ( (Feb.) ) 1934.
Frazier, C. N.:  Purpuric Vesiculobullous Dermatitis Subsequent to Injection of Sodium Thiosulfate , J. A. M. A. 88:537 ( (Feb. 19) ) 1927.
Baba, T.:  An Experimental Study of Treating Arsphenamine Intoxication , Jap. J. Dermat. & Urol. 24:43, 1924
abstr. Zentralbl. f. Haut- u. Geschlechtsker. 16:106, 1925.
Hesse, E.:  Die Entgiftungsmöglichkeiten der Metalle Co, Ag, HSb and As , Arch. f. exper. Path. u. Pharmakol. 122:354, 1927.
Link to Article[[XSLOpenURL/10.1007/BF01861790]]
Lehner, I.:  Natriumthiosulfat in der Therapie der Hautkrankheiten , Zentralbl. f. Haut- u. Geschlechtskr. 20:558, 1926.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.